EE200200314A - Tsüklilised kvaternaarsed ammooniumiühendid - Google Patents

Tsüklilised kvaternaarsed ammooniumiühendid

Info

Publication number
EE200200314A
EE200200314A EEP200200314A EEP200200314A EE200200314A EE 200200314 A EE200200314 A EE 200200314A EE P200200314 A EEP200200314 A EE P200200314A EE P200200314 A EEP200200314 A EE P200200314A EE 200200314 A EE200200314 A EE 200200314A
Authority
EE
Estonia
Prior art keywords
quaternary ammonium
ammonium compounds
cyclic quaternary
cyclic
compounds
Prior art date
Application number
EEP200200314A
Other languages
English (en)
Estonian (et)
Inventor
Siu Leung Choi Lewis
N. Beatch Gregory
P. Page Clive
Original Assignee
Ucb Farchim S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim S.A. filed Critical Ucb Farchim S.A.
Publication of EE200200314A publication Critical patent/EE200200314A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
EEP200200314A 1999-12-15 2000-12-15 Tsüklilised kvaternaarsed ammooniumiühendid EE200200314A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2292351 1999-12-15
PCT/CA2000/001506 WO2001044192A1 (en) 1999-12-15 2000-12-15 Cyclic quaternary ammonium compounds

Publications (1)

Publication Number Publication Date
EE200200314A true EE200200314A (et) 2003-08-15

Family

ID=4164887

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200314A EE200200314A (et) 1999-12-15 2000-12-15 Tsüklilised kvaternaarsed ammooniumiühendid

Country Status (19)

Country Link
US (1) US20030166629A1 (is)
EP (1) EP1278731A1 (is)
JP (1) JP2003516966A (is)
KR (1) KR20020074170A (is)
CN (1) CN1425005A (is)
AU (1) AU2334501A (is)
BG (1) BG106816A (is)
BR (1) BR0016431A (is)
CZ (1) CZ20022095A3 (is)
EE (1) EE200200314A (is)
HU (1) HUP0301686A2 (is)
IL (1) IL150179A0 (is)
IS (1) IS6417A (is)
MX (1) MXPA02006051A (is)
NO (1) NO20022870L (is)
PL (1) PL356032A1 (is)
WO (1) WO2001044192A1 (is)
YU (1) YU44102A (is)
ZA (1) ZA200205566B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2101819B1 (en) 2006-11-20 2013-01-09 President and Fellows of Harvard College Methods, compositions, and kits for treating pain and pruritis
MX2010009951A (es) * 2008-03-11 2011-09-01 Harvard College Metodos, composiciones y kits para tratar dolor y prurito.
EP2995303A1 (en) * 2009-07-10 2016-03-16 President and Fellows of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
WO2014085154A1 (en) 2012-11-27 2014-06-05 Beth Israel Deaconess Medical Center, Inc. Methods for treating renal disease
WO2015120069A1 (en) 2014-02-04 2015-08-13 Beth Israel Deaconess Medical Center, Inc. Methods and kits for the diagnosis and treatment of pancreatic cancer
WO2017024037A1 (en) * 2015-08-03 2017-02-09 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
EP3937945A4 (en) 2019-03-11 2023-01-04 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MA55307A (fr) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueurs de canaux ioniques chargés et procédés d'utilisation
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
BR112021017809A2 (pt) 2019-03-11 2021-11-23 Nocion Therapeutics Inc Bloqueadores de canais iônicos substituídos por éster e métodos para uso
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP7708777B2 (ja) 2020-03-11 2025-07-15 ノシオン セラピューティクス,インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI58632C (fi) * 1978-02-07 1981-03-10 Orion Yhtymae Oy Foerfarande foer framstaellning av anilider med antitussiv verkan

Also Published As

Publication number Publication date
BR0016431A (pt) 2002-10-01
AU2334501A (en) 2001-06-25
NO20022870L (no) 2002-08-14
NO20022870D0 (no) 2002-06-14
JP2003516966A (ja) 2003-05-20
IS6417A (is) 2002-06-12
ZA200205566B (en) 2003-11-17
IL150179A0 (en) 2002-12-01
CZ20022095A3 (cs) 2003-02-12
US20030166629A1 (en) 2003-09-04
MXPA02006051A (es) 2004-08-23
KR20020074170A (ko) 2002-09-28
BG106816A (en) 2003-04-30
CN1425005A (zh) 2003-06-18
HUP0301686A2 (hu) 2003-08-28
PL356032A1 (en) 2004-06-14
EP1278731A1 (en) 2003-01-29
WO2001044192A1 (en) 2001-06-21
YU44102A (sh) 2005-09-19

Similar Documents

Publication Publication Date Title
DE69905038D1 (de) Cyclische boroprolinverbindungen
ATE284389T1 (de) Zyklische n-acylamin-derivate
DE60022216D1 (de) Zusammensetzung umfassend quaternäre ammoniumsalze
NO2010019I1 (no) 6-per-deoksy-6-per-(2-karboksyl)tio-y-cyklodextrin
NO20016115L (no) Substituerte heterosykelkondenserte gamma-karbolin
DE69730151D1 (de) Cyclische sulfonderivate
DE60033715D1 (de) Servo-Regler
DK1261585T3 (da) Substituerede indol-Mannichbaser
FI4231U1 (fi) Kotelo
IS6417A (is) Sýklísk fjórgild ammóníum efnasambönd
DE50214377D1 (de) Neuartig konfektionierte quaternäre Ammoniumverbindungen
DE50101049D1 (de) Ammoniumgruppen aufweisende organosiliciumverbindungen
NO20013769D0 (no) Kalsilytiske forbindelser
DE60011850D1 (de) Absorber
DE60028852D1 (de) Fixiervorrichtung
NO20020466D0 (no) Kalsilytiske forbindelser
NO20014262D0 (no) Tiazoloindolinon-forbindelser
DE60000167D1 (de) Vibrationskreisel
DE60110046D1 (de) Cyclische hexapeptidderivate
NO20016392L (no) Antipsykotiske cykliske N-aralkylaminer
DE69923175D1 (de) Stabilisierte quaternäre ammoniumzusammensetzungen
AT3192U3 (de) Raumumschliessender bauteil
DE50003014D1 (de) N-substituierte perhydrodiazine
DE59904818D1 (de) Quartäre Ammoniumverbindungen
FI980268A0 (fi) Foerfarande foer framstaellning av cykliska monomerer